108 related articles for article (PubMed ID: 2473289)
1. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
Thiemermann C; Lidbury PS; Thomas GR; Vane JR
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
[TBL] [Abstract][Full Text] [Related]
2. Endothelins: potent releasers of prostacyclin and EDRF.
Botting RM; Vane JR
Pol J Pharmacol Pharm; 1990; 42(3):203-18. PubMed ID: 2263532
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
Vanderwel M; Haslam RJ
J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
[TBL] [Abstract][Full Text] [Related]
4. [Effect of protopine on rabbit platelet function].
Ma GY; Zhang ZZ; Chen ZH
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
Thiemermann C; May GR; Page CP; Vane JR
Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
[TBL] [Abstract][Full Text] [Related]
6. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
7. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
[TBL] [Abstract][Full Text] [Related]
8. The inducible nitric-oxide synthase modulates endothelin-1-dependent release of prostacyclin and inhibition of platelet aggregation ex vivo in the mouse.
Carrier E; Brochu I; de Brum-Fernandes AJ; D'Orléans-Juste P
J Pharmacol Exp Ther; 2007 Dec; 323(3):972-8. PubMed ID: 17885093
[TBL] [Abstract][Full Text] [Related]
9. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats.
Chintala MS; Bernardino V; Chiu PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1203-8. PubMed ID: 7996427
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
12. [Effects of neferine on platelet aggregation in rabbits].
Yu J; Hu WS
Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
[TBL] [Abstract][Full Text] [Related]
13. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
[TBL] [Abstract][Full Text] [Related]
14. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
16. Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase.
Roger S; Paysant J; Badier-Commander C; Cordi A; Verbeuren TJ; Félétou M
Vascul Pharmacol; 2010; 53(5-6):281-7. PubMed ID: 20933607
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-3: selectivity as an anti-aggregatory peptide in vivo.
Lidbury PS; Thiemermann C; Thomas GR; Vane JR
Eur J Pharmacol; 1989 Jul; 166(2):335-8. PubMed ID: 2676565
[TBL] [Abstract][Full Text] [Related]
19. Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity.
Anfossi G; Russo I; Massucco P; Mattiello L; Doronzo G; De Salve A; Trovati M
Eur J Clin Invest; 2004 Jul; 34(7):482-9. PubMed ID: 15255785
[TBL] [Abstract][Full Text] [Related]
20. Lithium inhibits adenylate cyclase of human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C
Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
